Company Profile
Edwards Lifesciences
Edwards Lifesciences builds structural heart and critical care technologies centered on transcatheter and hemodynamic innovation.
What They Build
Structural Heart and Critical Care Medical Technologies
Customer Type
Cardiac Programs, ICUs, Hospitals, Interventional Teams
Business Model
Device Sales and Clinical Support
Key Products & Initiatives
- Edwards is strongly associated with transcatheter aortic valve replacement leadership.
- Structural heart portfolio targets less-invasive treatment of complex valve disease.
- Critical care monitoring systems support perioperative and ICU decision making.
- Clinical evidence generation and physician training are central to adoption success.
- Product quality and long-term durability are high-priority engineering outcomes.
- Operations depend on tight coordination among R&D, manufacturing, clinical affairs, and regulatory teams.
Key Products & Brands
SAPIEN Platform
Structural HeartSAPIEN transcatheter heart valves are used in TAVR procedures to treat severe aortic stenosis in eligible patients. The platform is a major driver of minimally invasive structural heart adoption. Program success relies on outcomes data, procedural training, and hospital workflow fit.
Surgical and Transcatheter Mitral/Tricuspid Programs
Valve TherapiesEdwards develops therapies targeting mitral and tricuspid disease through surgical and catheter-based approaches. These products require careful evidence development and specialist training. Expansion in this area is strategically important for long-term growth.
HemoSphere and Critical Care Monitoring
Critical CareCritical care systems provide hemodynamic monitoring and clinical decision-support signals for ICU and OR settings. Teams use these tools to guide fluid management and cardiovascular care decisions. Reliability and signal clarity are essential in high-acuity workflows.
Lifesciences Clinical Support Ecosystem
Training and AdoptionEdwards provides physician training and procedural support programs to accelerate safe adoption of new therapies. These services are tightly linked to real-world outcomes and platform utilization. Clinical partnership quality is a key operating differentiator.
Role Families
R&D & Biomedical Engineering
Expected Skills
What They Work On
- Designing transcatheter and monitoring devices with strict safety and performance requirements.
- Building test and validation frameworks for regulated cardiovascular technologies.
- Optimizing manufacturing transfer and product reliability for high-volume clinical use.
Portfolio Ideas
- Build a catheter-device validation plan with measurable performance thresholds.
- Create a reliability growth model for implantable device lifecycle testing.
- Prototype a design-control traceability matrix from user needs to verification evidence.
Clinical Operations & Quality
Expected Skills
What They Work On
- Tracking post-market safety signals and quality trends across deployed therapies.
- Supporting clinical study operations and evidence packages for regulatory submissions.
- Managing CAPA and compliance workflows tied to global medtech requirements.
Portfolio Ideas
- Build a post-market signal analytics dashboard for structural heart products.
- Create a CAPA prioritization framework tied to recurrence and severity.
- Design a clinical evidence milestone tracker aligned to submission readiness.
Entry Pathways
internships
Edwards internships include engineering, clinical, quality, and operations tracks with practical project ownership. Interns often support validation, process, or analytics work tied to active programs. Hiring emphasizes technical discipline and patient-safety orientation.
entry Level Roles
Entry opportunities include R&D engineering, quality, regulatory, and clinical operations support. Candidates with strong test rigor and documentation quality are competitive. Understanding cardiovascular procedure context is a differentiator.
graduate Programs
Early-career hiring includes direct team roles and selected development pathways depending on function. New graduates are expected to learn regulated medtech workflows quickly and collaborate across clinical and engineering teams. Internship conversion is a common path.
Culture Signals
Edwards consistently emphasizes patient outcomes and clinician partnership quality.
Clinical evidence and scientific rigor are central to product strategy.
Quality/compliance discipline is tightly integrated with engineering execution.
Training and adoption support are treated as core to real-world therapy success.
Cross-functional collaboration across clinical, regulatory, and product teams is expected.